EIR Pharmaceuticals, LLC — Form D/A

EIR Pharmaceuticals, LLC of Olathe, KS, a company, filed a Form D amendment with the SEC on 2019-09-09. $70K was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2019-09-09
• Form: D/A
• Accession: 0001786037-19-000002
• Industry: Pharmaceuticals
• Exemptions: 06b
• Amount sold: $70K
• Minimum investment: $1
• Investors: 3
• Date of first sale: 2019-08-16
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-347715

Issuer

• Name: EIR Pharmaceuticals, LLC
• CIK: 0001786037
• Entity type: Limited Liability Company
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: 10900 South Clay Blair Boulevard, Olathe, KS, 66061
• Phone: (515) 231-0874

Officers, directors & promoters (1)

Other filings by this issuer (1)

More

• CIK 1786037 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search